Camille Sibertin-Blanc

Clinical outcome after biliary drainage for metastatic colorectal cancer: Survival analysis and prognostic factors.

J. Gaudart, R. Laugier, P. Grandval, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Monoclonal antibodies for treating gastric cancer: promises and pitfalls

B. Lacarelle, J. Seitz, J. Ciccolini, 2016, Expert opinion on biological therapy.

Chemoembolization with Epirubicin in the Treatment of Malignant Insulinoma

J. Seitz, L. Dahan, M. Duluc, 2017 .

Nutritional status and quality of life of cancer patients needing exclusive chemotherapy: a longitudinal study

K. Baumstarck, P. Auquier, S. Salas, 2017, Health and Quality of Life Outcomes.

Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report

J. Seitz, L. Dahan, M. Duluc, 2013, BMC Research Notes.

Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial

J. Taïeb, S. Olschwang, V. Boige, 2022, Therapeutic advances in medical oncology.

Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with bevacizumab efficacy and related hypertension in metastatic colorectal cancer.

A. Fabre, N. Lévy, S. Olschwang, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Geriatric Profile of Elderly Patients Treated For Pancreatic Cancer: The Oncogepan Database

J. Raoul, J. Seitz, J. Delpero, 2017 .

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

N. Magné, B. Chauffert, F. Ducray, 2020, European Journal of Cancer.

Impact of genetic polymorphisms of VEGF pathway on the response to bevacizumab in metastatic colorectal cancer (mCRC): Ancillary study of PRODIGE 9 trial.

S. Olschwang, V. Boige, O. Bouché, 2016 .

Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with bevacizumab efficacy and related hypertension in metastatic colorectal cancer.

A. Fabre, N. Lévy, S. Olschwang, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.